MARK RODRIGUEZ: Open Payments
NPI 1982708111 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,818 in 150 payments from 24 companies in 2025. Trend: 2023 $2,954 · 2024 $2,931 · 2025 $2,818
Food & beverage: $2,818
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 26 | $583 |
| PFIZER INC. | 40 | $461 |
| Axsome Therapeutics, Inc. | 9 | $281 |
| Corcept Therapeutics | 6 | $228 |
| ABBVIE INC. | 15 | $215 |
| Novo Nordisk Inc | 5 | $206 |
| Xeris Pharmaceuticals, Inc. | 17 | $192 |
| Esperion Therapeutics, Inc. | 5 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $56 |
| Amgen Inc. | 3 | $54 |
Products named: Kerendia, Symbravo, Korlym, NURTEC ODT, KEVEYIS, Ozempic, ZAVZPRET, VRAYLAR.
Industry payments across TX — which companies pay providers there.
